Education
About Us
Working with TipRanks
Follow Us
IGM Biosciences Inc (IGMS)
NASDAQ:IGMS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.68M | $ 2.13M | $ 1.07M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 2.68M | $ -6.15M | $ -9.53M | $ -7.72M | $ -3.58M |
| Operating Income | $ -208.58M | $ -263.46M | $ -227.96M | $ -165.32M | $ -83.28M |
| EBITDA | $ -208.58M | $ -253.36M | $ -221.88M | $ -157.44M | $ -77.78M |
| Net Income | $ -195.79M | $ -246.42M | $ -214.25M | $ -160.68M | $ -80.33M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 183.79M | $ 337.68M | $ 427.16M | $ 229.54M | $ 366.27M |
| Total Assets | $ 265.71M | $ 423.41M | $ 513.50M | $ 298.13M | $ 408.63M |
| Total Debt | $ 45.19M | $ 40.51M | $ 41.17M | $ 28.76M | $ 12.24M |
| Net Debt | $ 18.69M | $ -72.01M | $ -80.06M | $ -104.58M | $ -228.84M |
| Total Liabilities | $ 217.54M | $ 220.18M | $ 226.24M | $ 53.22M | $ 26.82M |
| Stockholders' Equity | $ 48.17M | $ 203.23M | $ -574.83M | $ -353.72M | $ -188.56M |
| Cash Flow | |||||
| Free Cash Flow | $ -158.85M | $ -204.61M | $ -16.06M | $ -137.58M | $ -84.81M |
| Operating Cash Flow | $ -153.00M | $ -192.23M | $ -5.85M | $ -124.34M | $ -67.30M |
| Investing Cash Flow | $ 64.16M | $ 68.36M | $ -225.64M | $ 14.82M | $ 57.71M |
| Financing Cash Flow | $ 2.39M | $ 115.07M | $ 219.38M | $ 2.48M | $ 214.78M |